×
About 155 results

ALLMedicine™ Adrenal Cancer Center

Research & Reviews  50 results

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305057
Endocrine Berruti A, Terzolo M et. al.

Jul 23rd, 2022 - Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021.|2022|Berruti A,Terzolo M,Filetti S,|

Massive adrenocortical carcinoma presenting as peripheral edema: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210600
Journal of Medical Case Reports; Goodkin DA

Jun 21st, 2022 - Adrenocortical carcinoma is a rare, but potentially lethal, malignancy that is usually detected as an incidental finding on abdominal imaging studies or owing to hormonal complications. This report recounts an unusual presentation with leg edema d...

Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?
https://doi.org/10.1007/s12020-022-03066-z
Endocrine Perge P, Nyirő G et. al.

May 14th, 2022 - Almost 10 years have passed since the first attempts of liquid biopsy aimed at the characterisation of tumor cells present in the bloodstream from a regular sample of peripheral blood were performed. Liquid biopsy has been used to characterise tum...

Novel CYP11B-ligand 123/131IIMAZA as promising theranostic tool for adrenocortical tumo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712301
European Journal of Nuclear Medicine and Molecular Imaging; Heinze B, Schirbel A et. al.

Jul 4th, 2021 - Adrenal tumors represent a diagnostic and therapeutic challenge. Promising results have been obtained through targeting the cytochrome P450 enzymes CYP11B1 and CYP11B2 for molecular imaging, and [123/131I]iodometomidate ([123/131I]IMTO) has even b...

Adrenal cancer: relevance of different grading systems and subtypes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192347
Clinical & Translational Oncology : Official Publication ... Minner S, Schreiner J et. al.

Apr 6th, 2021 - The subclassification of adrenal cancers according to the WHO classification in ordinary, myxoid, oncocytic, and sarcomatoid as well as pediatric types is well established, but the criteria for each subtype are not sufficiently determined and the ...

see more →

Guidelines  1 results

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
https://doi.org/10.1093/annonc/mds231
Annals of Oncology : Official Journal of the European Soc... Berruti A, Baudin E et. al.

Nov 20th, 2012 - Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2012|Berruti A,Baudin E,Gelderblom H,Haak HR,Porpiglia F,|diagnosis,pathology,therapy,diagnosis,secondary,therapy,therapeutic use,therapeutic use,therapeutic...

see more →

Clinicaltrials.gov  3 results

Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card
https://clinicaltrials.gov/ct2/show/NCT02672020

Sep 24th, 2019 - Malignant pheochromocytoma/paraganglioma (MPP) and adrenocortical carcinoma (ACC) are two rare cancer entities with a very unfavorable prognosis. The knowledge on these rare cancers improved thanks to the French COMETE ('COrtex, MEdulla Tumors End...

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
https://clinicaltrials.gov/ct2/show/NCT00094497

Sep 21st, 2016 - The Firm-ACT trial is the first ever conducted randomized controlled phase III trial in adrenocortical carcinoma (ACC), a rare malignancy with poor prognosis. It will provide results leading to the establishment of an urgently needed gold standard...

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT00002608

Jul 10th, 2013 - OBJECTIVES: Determine the feasibility and efficacy of cisplatin, doxorubicin, and tamoxifen (CAT) in patients with soft tissue sarcoma, glioma, mesothelioma, hepatoma, thyroid cancer, or adrenal cancer. Determine the toxicity of this regimen in th...

see more →

News  5 results

Cushing Death Rate 'Unacceptable,' Triple That of General Population
https://www.medscape.com/viewarticle/949257

Apr 14th, 2021 - Excess mortality among people with endogenous Cushing syndrome (CS) has declined in the past 20 years yet remains three times higher than in the general population, new research finds. Among more than 90,000 individuals with endogenous CS, the ove...

Urine Screen as Part of Triple Test Improves ID of Adrenal Cancer
https://www.medscape.com/viewarticle/934790

Jul 29th, 2020 - A strategy that includes a urine steroid test along with imaging characteristics and tumor size criteria can significantly improve the challenging diagnosis of adrenocortical cancer, helping to avoid unnecessary, and often unsuccessful, further im...

Post-Stenting DAPT; Incidentalomas: It's PodMed Double T!
https://www.medpagetoday.com/cardiology/myocardialinfarction/80770

Jun 29th, 2019 - PodMed Double T is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, look at the top me...

Endocrine Society to the White House: Immigration ban undermines science
https://www.mdedge.com/endocrinology/article/130649/practice-management/endocrine-society-white-house-immigration-ban
Sally Koch Kubetin

Feb 2nd, 2017 - The immigration ban from seven Muslim-majority countries issued recently by the Trump administration is having the unintended effect of disrupting scientific collaboration, according to a statement issued by the Endocrine Society. “President Donal.

Interventional Cardiologist Donald Baim Dies
https://www.medscape.com/viewarticle/712050

Nov 9th, 2009 - November 9, 2009 (Boston, Massachusetts) — Interventional cardiologist Dr Donald Baim, chief medical and scientific officer at Boston Scientific, has died due to complications of surgery for treating recently diagnosed adrenal cancer. A message se...

see more →

Patient Education  3 results see all →